{"id":23459,"date":"2021-01-04T12:40:00","date_gmt":"2021-01-04T12:40:00","guid":{"rendered":"https:\/\/sagaciousresearch.com\/blog\/?p=23459"},"modified":"2022-06-29T14:04:20","modified_gmt":"2022-06-29T14:04:20","slug":"technology-networks-drug-repurposing-advantages-and-key-approaches","status":"publish","type":"post","link":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches","title":{"rendered":"Technology Networks &#8211; Drug Repurposing: Advantages and Key Approaches"},"content":{"rendered":"\n<p>Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are beyond the scope of the original medical indication. This approach offers several advantages over developing a novel drug for a given indication. Various data-driven and experimental approaches have been recommended for the identification of drug candidates that can be repurposed. However, there are some major regulatory as well as technological challenges that need to be addressed.<br><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_81 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a04b0c2c8bce\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a04b0c2c8bce\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\/#Advantages_of_repurposing_drugs\" >Advantages of repurposing drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\/#Popular_approaches_for_repurposing_drugs\" >Popular approaches for repurposing drugs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\/#Repurposing_oncology_drugs\" >Repurposing oncology drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\/#Repositioning_drugs_across_therapeutic_areas\" >Repositioning drugs across therapeutic areas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\/#Aspirin_The_versatile_drug\" >Aspirin: The versatile drug<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\/#Repositioning_drugs_for_rare_diseases\" >Repositioning drugs for rare diseases<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\/#Repurposing_drugs_to_treat_COVID-19\" >Repurposing drugs to treat COVID-19<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\/#Way_forward\" >Way forward<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Advantages_of_repurposing_drugs\"><\/span><strong>Advantages of repurposing drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Notably, the drug repurposing approach benefits from the fact that approved medicines and several discarded compounds have already been tested in humans and comprehensive information is available on their pharmacology, dose, possible toxicity and formulation. Drug repurposing has numerous advantages&nbsp;over conventional drug discovery approaches, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Considerably cuts research and development (R&amp;D) costs.<\/li><li>Reduces the drug development timeline, as various existing compounds have already demonstrated safety in humans, it does not require Phase 1 clinical trials.<\/li><li>Potential for reuse despite evidence of adverse effects and failed efficacy in some indications.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Popular_approaches_for_repurposing_drugs\"><\/span><strong>Popular approaches for repurposing drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Drug repurposing has now become a significant part of the pharmaceutical industry. There are several drugs that have been \u2013 or are currently being repurposed \u2013 for novel indications. Repurposing can occur at <a href=\"https:\/\/www.technologynetworks.com\/drug-discovery\/articles\/exploring-the-drug-development-process-331894\" target=\"_blank\" rel=\"noreferrer noopener\">various stages of the drug development and approval process<\/a>. Below we list some popular drug repurposing approaches.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Repurposing_oncology_drugs\"><\/span><strong>Repurposing oncology drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The drug repositioning\/recycling approach has actively and effectively been adopted by drug discovery researchers and the pharmaceutical industry, especially within the oncology space. Oncology drugs are originally developed for a particular cancer. However, they can then be clinically investigated in other similar tumor types, producing versatile drugs.<\/p>\n\n\n\n<p>Cancer appears appropriate for repurposing drugs as a single mechanism or biomarker is frequently linked to a broad range of tumor types. One prominent cancer immunotherapy is Merck\u2019s <a href=\"https:\/\/www.keytruda.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Keytruda\u00ae (pembrolizumab)<\/a> which was first approved for advanced melanoma. Today, it is approved for 14 cancer types, including lung cancer and lymphoma. The company is constantly evaluating Keytruda for more cancers, such as triple-negative breast cancer. Notably, Keytruda is a programmed cell death-1 (PD-1) inhibitor that acts by blocking the PD-1 receptor and its interaction with ligands which helps to activate a T-cell mediated immune response against tumor cells. Due to its similar PD-1-based mechanism of action (MOA), Bristol-Myers Squibb\u2019s (BMS) <a href=\"https:\/\/www.opdivo.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Opdivo\u00ae (nivolumab)<\/a> is currently approved for 10 cancer types and the company is continuing to investigate the drug\u2019s efficacy for other indications.<\/p>\n\n\n\n<p>Novartis\u2019 drug Arzerra (ofatumumab), a monoclonal antibody that targets the CD20 protein, was initially developed to treat chronic lymphocytic leukemia (CLL). However, <a href=\"https:\/\/www.mssociety.org.uk\/research\/explore-our-research\/emerging-research-and-treatments\/explore-treatments-in-trials\/ofatumumab#:~:text=Ofatumumab%20(also%20known%20as%20Arzerra,being%20developed%20for%20relapsing%20MS.&amp;text=Phase%202%20trials%20were%20completed,carry%20out%20late%20stage%20trial.\" target=\"_blank\" rel=\"noreferrer noopener\">clinical studies are currently underway<\/a> to determine its effectiveness as a treatment for adult patients with relapsing forms of multiple sclerosis (MS).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Repositioning_drugs_across_therapeutic_areas\"><\/span><strong>Repositioning drugs across therapeutic areas<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Apart from repositioning drugs <em>within<\/em> a particular disease area, the pharmaceutical industry is also evaluating whether drugs approved for one indication have the potential to benefit patients in an entirely different therapeutic area. Non-oncology drugs, for example, are often repurposed to treat various cancers. For instance, experiments have shown that <a href=\"https:\/\/www.karger.com\/Article\/FullText\/481224\" target=\"_blank\" rel=\"noreferrer noopener\">clarithromycin is effective in <em>H. pylori<\/em>-associated cancers<\/a> such as mucosa\u2010associated lymphoid tissue (MALT) lymphoma. Furthermore, studies have proven its efficacy in other cancer types, including multiple myeloma and chronic myeloid leukemia (CML). The main mechanisms by which clarithromycin exhibits anti-cancer properties are prolonged reduction in pro-inflammatory cytokines, anti-angiogenesis and inhibition of autophagy. This antibiotic\u2019s efficacy in cancer is improved when it is combined with existing cancer drugs targeting other aspects of tumor activity.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aspirin_The_versatile_drug\"><\/span><strong>Aspirin: The versatile drug<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Aspirin (acetylsalicylic acid) is a powerful drug that is not only being evaluated in the oncology field, but also in cardiac-related indications such as myocardial infarction. Studies show that low doses of the drug reduce the risk of developing a broad range of cancer types, including colorectal and pancreatic cancers.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Repositioning_drugs_for_rare_diseases\"><\/span><strong>Repositioning drugs for rare diseases<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>It is common knowledge that there are only a few therapeutic options for rare diseases \u2013 those that affect only a small percentage of the overall population. After the discovery of its immunosuppressive properties linked to its inhibition of the mTOR protein kinase, Pfizer\u2019s Rapamune\u00ae (sirolimus) was approved to prevent organ transplant rejection. It also became the <a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer_s_rapamune_sirolimus_becomes_first_fda_approved_treatment_for_lymphangioleiomyomatosis_lam_a_rare_progressive_lung_disease\" target=\"_blank\" rel=\"noreferrer noopener\">first drug approved for lymphangioleiomyomatosis (LAM)<\/a>, a rare genetic lung disease.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Repurposing_drugs_to_treat_COVID-19\"><\/span><strong>Repurposing drugs to treat COVID-19<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Drugs are also being repurposed as a treatment strategy against COVID-19 \u2013 the disease caused by SARS-CoV-2. Several drugs are being evaluated including AbbVie\u2019s Kaletra\u00ae (lopinavir\/ritonavir), and Ascletis Pharma\u2019s Ganovo\u00ae (danoprevir) plus ritonavir and other combinations. Furthermore, Gilead Pharmeceuticals\u2019 Veklury\u00ae (remdesivir) has been <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-covid-19#:~:text=Today%2C%20the%20U.S.%20Food%20and,of%20COVID%2D19%20requiring%20hospitalization.\" target=\"_blank\" rel=\"noreferrer noopener\">approved by the US Food and Drug Administration (FDA)<\/a> as a treatment for COVID-19.<br><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Way_forward\"><\/span><strong>Way forward<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Due to soaring drug prices and the slow pace of drug discovery and development, repurposing existing drugs to treat diseases other than their originally approved indication is becoming an increasingly attractive proposition. Such drugs will likely soon capture a significant portion of the pharmaceutical industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are beyond the scope of the original medical indication. This approach offers several advantages&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":23923,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"coauthors":[983],"class_list":["post-23459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media-spotlights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Technology Networks - Drug Repurposing: Advantages and Key Approaches - Sagacious IP<\/title>\n<meta name=\"description\" content=\"Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Technology Networks - Drug Repurposing: Advantages and Key Approaches - Sagacious IP\" \/>\n<meta property=\"og:description\" content=\"Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\" \/>\n<meta property=\"og:site_name\" content=\"Sagacious IP\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T12:40:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-29T14:04:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2119\" \/>\n\t<meta property=\"og:image:height\" content=\"1211\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Vilas Karnake\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Vilas Karnake\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#article\",\"isPartOf\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\"},\"author\":{\"name\":\"Vilas Karnake\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/person\/ee18415b4ec48919d929dd9732c9749f\"},\"headline\":\"Technology Networks &#8211; Drug Repurposing: Advantages and Key Approaches\",\"datePublished\":\"2021-01-04T12:40:00+00:00\",\"dateModified\":\"2022-06-29T14:04:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\"},\"wordCount\":831,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg\",\"articleSection\":[\"Media Spotlights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\",\"url\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\",\"name\":\"Technology Networks - Drug Repurposing: Advantages and Key Approaches - Sagacious IP\",\"isPartOf\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg\",\"datePublished\":\"2021-01-04T12:40:00+00:00\",\"dateModified\":\"2022-06-29T14:04:20+00:00\",\"description\":\"Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are\",\"breadcrumb\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#primaryimage\",\"url\":\"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg\",\"contentUrl\":\"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg\",\"width\":2119,\"height\":1211,\"caption\":\"drug repurposing\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sagaciousresearch.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Technology Networks &#8211; Drug Repurposing: Advantages and Key Approaches\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#website\",\"url\":\"https:\/\/sagaciousresearch.com\/blog\/\",\"name\":\"Sagacious IP\",\"description\":\"Blog\",\"publisher\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sagaciousresearch.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#organization\",\"name\":\"Sagacious IP\",\"url\":\"https:\/\/sagaciousresearch.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2022\/06\/cropped-cropped-cropped-sagacious-ip-logo80-1-1.png\",\"contentUrl\":\"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2022\/06\/cropped-cropped-cropped-sagacious-ip-logo80-1-1.png\",\"width\":481,\"height\":80,\"caption\":\"Sagacious IP\"},\"image\":{\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/person\/ee18415b4ec48919d929dd9732c9749f\",\"name\":\"Vilas Karnake\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/person\/image\/d7edb6a9166e3680603701ae9e10e107\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/363be32d5f469b83f76184b09a333c02c746a62144121a8dcfc89b20ff076462?s=96&d=initials&r=g&initials=vk\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/363be32d5f469b83f76184b09a333c02c746a62144121a8dcfc89b20ff076462?s=96&d=initials&r=g&initials=vk\",\"caption\":\"Vilas Karnake\"},\"url\":\"https:\/\/sagaciousresearch.com\/blog\/author\/adm.vkarnake\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Technology Networks - Drug Repurposing: Advantages and Key Approaches - Sagacious IP","description":"Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches","og_locale":"en_US","og_type":"article","og_title":"Technology Networks - Drug Repurposing: Advantages and Key Approaches - Sagacious IP","og_description":"Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are","og_url":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches","og_site_name":"Sagacious IP","article_published_time":"2021-01-04T12:40:00+00:00","article_modified_time":"2022-06-29T14:04:20+00:00","og_image":[{"width":2119,"height":1211,"url":"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg","type":"image\/jpeg"}],"author":"Vilas Karnake","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Vilas Karnake","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#article","isPartOf":{"@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches"},"author":{"name":"Vilas Karnake","@id":"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/person\/ee18415b4ec48919d929dd9732c9749f"},"headline":"Technology Networks &#8211; Drug Repurposing: Advantages and Key Approaches","datePublished":"2021-01-04T12:40:00+00:00","dateModified":"2022-06-29T14:04:20+00:00","mainEntityOfPage":{"@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches"},"wordCount":831,"commentCount":0,"publisher":{"@id":"https:\/\/sagaciousresearch.com\/blog\/#organization"},"image":{"@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#primaryimage"},"thumbnailUrl":"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg","articleSection":["Media Spotlights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#respond"]}]},{"@type":"WebPage","@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches","url":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches","name":"Technology Networks - Drug Repurposing: Advantages and Key Approaches - Sagacious IP","isPartOf":{"@id":"https:\/\/sagaciousresearch.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#primaryimage"},"image":{"@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#primaryimage"},"thumbnailUrl":"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg","datePublished":"2021-01-04T12:40:00+00:00","dateModified":"2022-06-29T14:04:20+00:00","description":"Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are","breadcrumb":{"@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#primaryimage","url":"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg","contentUrl":"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2021\/01\/1-40-31.jpg","width":2119,"height":1211,"caption":"drug repurposing"},{"@type":"BreadcrumbList","@id":"https:\/\/sagaciousresearch.com\/blog\/technology-networks-drug-repurposing-advantages-and-key-approaches#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sagaciousresearch.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Technology Networks &#8211; Drug Repurposing: Advantages and Key Approaches"}]},{"@type":"WebSite","@id":"https:\/\/sagaciousresearch.com\/blog\/#website","url":"https:\/\/sagaciousresearch.com\/blog\/","name":"Sagacious IP","description":"Blog","publisher":{"@id":"https:\/\/sagaciousresearch.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sagaciousresearch.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/sagaciousresearch.com\/blog\/#organization","name":"Sagacious IP","url":"https:\/\/sagaciousresearch.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2022\/06\/cropped-cropped-cropped-sagacious-ip-logo80-1-1.png","contentUrl":"https:\/\/sagaciousresearch.com\/blog\/wp-content\/uploads\/2022\/06\/cropped-cropped-cropped-sagacious-ip-logo80-1-1.png","width":481,"height":80,"caption":"Sagacious IP"},"image":{"@id":"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/person\/ee18415b4ec48919d929dd9732c9749f","name":"Vilas Karnake","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sagaciousresearch.com\/blog\/#\/schema\/person\/image\/d7edb6a9166e3680603701ae9e10e107","url":"https:\/\/secure.gravatar.com\/avatar\/363be32d5f469b83f76184b09a333c02c746a62144121a8dcfc89b20ff076462?s=96&d=initials&r=g&initials=vk","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/363be32d5f469b83f76184b09a333c02c746a62144121a8dcfc89b20ff076462?s=96&d=initials&r=g&initials=vk","caption":"Vilas Karnake"},"url":"https:\/\/sagaciousresearch.com\/blog\/author\/adm.vkarnake"}]}},"_links":{"self":[{"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/posts\/23459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/comments?post=23459"}],"version-history":[{"count":1,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/posts\/23459\/revisions"}],"predecessor-version":[{"id":23461,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/posts\/23459\/revisions\/23461"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/media\/23923"}],"wp:attachment":[{"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/media?parent=23459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/categories?post=23459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/tags?post=23459"},{"taxonomy":"categories","embeddable":true,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/categories?post=23459"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/sagaciousresearch.com\/blog\/wp-json\/wp\/v2\/coauthors?post=23459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}